Pfizer Inc.’s .  puts a question mark over a major project the U.K. company is in the middle of executing–the relocation of its corporate headquarters and research labs to Cambridge, England.. AstraZeneca has hired architects for a new $500 million site near Cambridge University and has begun the process of moving 2,000 scientists and executives there from London and northwest England by 2016. Some AstraZeneca scientists already have started working in Cambridge, where they are busy .  with the town’s many labs and hospitals.